CGEN Q1 2024 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$457,00017.9% margin

Operating Income

-$8M-331.8% margin

Net Income

-$7M-284.0% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-92.4%

Balance Sheet

Total Assets

$114M

Total Liabilities

$54M

Stockholders' Equity

$60M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$457,000	$0	—
Operating Income	-$8M	-$10M	+16.2%
Net Income	-$7M	-$9M	+22.2%